[The use of MCNU to a patient of primary myelofibrosis complicated with pericardial effusion and proteinuria].
A case of primary myelofibrosis complicated with pericardial effusion and proteinuria is described. A 66-year-old female was admitted to our hospital because of abdominal fullness and shortness of breath. On admission, hepatosplenomegaly and pericardial effusion were observed. Blood examination revealed leukoerythroblastic anemia and thrombocytosis with tear drop cells and giant platelets. Bone marrow aspiration was dry tap and its biopsy showed remarkable myelofibrosis. Urinalysis indicated severe proteinuria. Although neutrophilic alkaline phosphatase score was low, no signs of acute blastic crisis of chronic myelogenous leukemia was found. The diagnosis of an atypical type of primary myelofibrosis was obtained. Administration of MCNU was started in August 1987. Hepatosplenomegaly, pericardial effusion and proteinuria were gradually improved after the administration. The etiology of the pericardial effusion and proteinuria were not obvious, however, these facts suggest that these abnormal findings might be related to PMF itself and MCNU was effective to PNF.
Y
Y
Shiga
R
R
Matsuoka
R
R
Abe
S
S
Matsuda
T
T
Uchida
S
S
Kariyone
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D010490:Pericardial Effusion / Q000209:etiology*; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D011507:Proteinuria / Q000209:etiology*
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; C020766:ranimustine